{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:50:53Z","timestamp":1785797453113,"version":"3.56.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013053","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000}}],"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Chagas disease is a major health issue in Latin America and is now spreading globally because of migration. Chronic Chagasic cardiomyopathy (CCC) leads to heart failure with a reduced ejection fraction (HFrEF). Left ventricular reverse remodeling (LVRR), defined as an improved LVEF, is associated with improved outcomes in patients with other HFrEF etiologies. Therefore, we evaluated the relationship between LVRR and survival in CCC patients with an LVEF&lt;40%.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This retrospective, single-center study included patients diagnosed with CCC and LVEF&lt;40% between January 2006 and September 2021. Patients were divided into two groups: positive RR (PRR; LVEF\u226540% or an absolute LVEF increase of\u2009\u2265\u200910%) and negative RR (NRR). Propensity score matching (PSM) was used to account for baseline differences, and Cox proportional hazards models were applied to determine independent predictors of mortality and heart transplantation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 1,043 patients were evaluated; 221 (21.2%) were classified as having PRR, and 822 (78.8%) were classified as having NRR. PRR status was associated with a 55% lower risk of all-cause mortality and heart transplantation over 15 years (p\u2009=\u20090.002). Multivariate Cox analysis revealed that predictors of total mortality and heart transplantation included NRR status, a worse NYHA class, lower serum sodium levels, larger LV dimensions, and moderate-to-severe tricuspid regurgitation (TR). The PRR predictors were smaller LV dimensions, less mitral regurgitation, and the absence of triple therapy at baseline. NRR patients were more likely to be on triple therapy at baseline.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>PRR improves survival in CCC patients with HFrEF. Identifying patients with potential for LVRR, alongside early therapeutic interventions, may reduce mortality in this population. Future research should focus on therapies that promote LVRR in patients with CCC.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0013053","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:41:44Z","timestamp":1745430104000},"page":"e0013053","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Left ventricular reverse remodeling: A predictor of survival in chagasic cardiomyopathy patients with a reduced ejection fraction"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-1193","authenticated-orcid":true,"given":"Maria Tereza Sampaio de Sousa","family":"Lira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silas Ramos","family":"Furquim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Catto de","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela Camara","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Cavalcanti Tourinho","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Biselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Roberto","family":"Chizzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson Tadeu","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Jos\u00e9 Alvarez","family":"Ramires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Maria","family":"Ianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Moreira","family":"Ayub-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Gomes","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edimar Alcides","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"3","key":"pntd.0013053.ref001","doi-asserted-by":"crossref","first-page":"100507","DOI":"10.1016\/j.cpcardiol.2019.100507","article-title":"Chagas Disease: Chronic Chagas Cardiomyopathy","volume":"46","author":"NG Echavarr\u00eda","year":"2021","journal-title":"Curr Probl Cardiol"},{"issue":"12","key":"pntd.0013053.ref002","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2017.08.004","article-title":"Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment","volume":"70","author":"EA Bocchi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"pntd.0013053.ref003","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000526986","article-title":"Prediction of Left Ventricular Reverse Remodelling: A Mini Review on Clinical Aspects","volume":"147","author":"M Chud\u00fd","year":"2022","journal-title":"Cardiology"},{"issue":"4","key":"pntd.0013053.ref004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/CRD.0000000000000068","article-title":"Reverse Remodeling in Systolic Heart Failure","volume":"23","author":"T Saraon","year":"2015","journal-title":"Cardiol Rev"},{"issue":"4","key":"pntd.0013053.ref005","article-title":"Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes","volume":"9","author":"Jr Nadruz W","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"3","key":"pntd.0013053.ref006","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCHEARTFAILURE.113.000813","article-title":"Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after \u03b2-blocker therapy","volume":"7","author":"P de Groote","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"12","key":"pntd.0013053.ref007","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/ejhf.824","article-title":"Recovered heart failure with reduced ejection fraction and outcomes: a prospective study","volume":"19","author":"J Lup\u00f3n","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"pntd.0013053.ref008","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","article-title":"Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment","volume":"57","author":"M Merlo","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pntd.0013053.ref009","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamacardio.2016.1325","article-title":"Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction","volume":"1","author":"AP Kalogeropoulos","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"1","key":"pntd.0013053.ref010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5603\/CJ.a2020.0038","article-title":"Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?","volume":"29","author":"MA Nakazone","year":"2022","journal-title":"Cardiol J"},{"key":"pntd.0013053.ref011","article-title":"Control of Chagas disease","volume":"905","author":"WHO Expert Committee","year":"2002","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"3","key":"pntd.0013053.ref012","first-page":"436","article-title":"Diretriz Brasileira de Insufici\u00eancia Card\u00edaca Cr\u00f4nica e Aguda","volume":"111","author":"Comit\u00ea Coordenador da Diretriz de Insufici\u00eancia Card\u00edaca","year":"2018","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"pntd.0013053.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography","volume":"32","author":"C Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"pntd.0013053.ref014","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ejcts\/ezu511","article-title":"Negative impact of atrial fibrillation and pulmonary hypertension after mitral valve surgery in asymptomatic patients with severe mitral regurgitation: a 20-year follow-up","volume":"48","author":"GF Coutinho","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"pntd.0013053.ref015","doi-asserted-by":"crossref","first-page":"646097","DOI":"10.3389\/fendo.2021.646097","article-title":"Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism","volume":"12","author":"C-T Pan","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"pntd.0013053.ref016","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jjcc.2020.09.004","article-title":"Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy","volume":"77","author":"H Yokoyama","year":"2021","journal-title":"J Cardiol"},{"issue":"6","key":"pntd.0013053.ref017","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1002\/ehf2.14107","article-title":"Clinical impacts of sacubitril\/valsartan on patients eligible for cardiac resynchronization therapy","volume":"9","author":"H-T Huang","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"23","key":"pntd.0013053.ref018","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"issue":"18","key":"pntd.0013053.ref019","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure","volume":"273","author":"R Garg","year":"1995","journal-title":"JAMA"},{"issue":"4","key":"pntd.0013053.ref020","first-page":"273","article-title":"Beneficial effects of enalapril on the diastolic ventricular function in Chagas myocardiopathy","volume":"60","author":"FE Szajnbok","year":"1993","journal-title":"Arq Bras Cardiol"},{"issue":"21","key":"pntd.0013053.ref021","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"M Packer","year":"1996","journal-title":"N Engl J Med"},{"issue":"10","key":"pntd.0013053.ref022","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"B Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"pntd.0013053.ref023","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1002\/ehf2.13630","article-title":"Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction","volume":"8","author":"X Zhang","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"26","key":"pntd.0013053.ref024","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/eurheartj\/ehz233","article-title":"Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study","volume":"40","author":"A Ghimire","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"pntd.0013053.ref025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.cardfail.2023.06.022","article-title":"Heart Failure With Recovered Ejection Fraction in Patients With Nonischemic Cardiomyopathy: Characteristics, Outcomes, and Long-term Follow-up","volume":"29","author":"Y Hammer","year":"2023","journal-title":"J Card Fail"},{"issue":"4","key":"pntd.0013053.ref026","article-title":"Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes","volume":"9","author":"Jr Nadruz W","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"5","key":"pntd.0013053.ref027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001193","article-title":"Left ventricular diameter and risk stratification for sudden cardiac death","volume":"3","author":"K Narayanan","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"pntd.0013053.ref028","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas\u2019 heart disease","volume":"355","author":"Jr Rassi A","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"pntd.0013053.ref029","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCIMAGING.122.014988","article-title":"Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure","volume":"16","author":"D Cocianni","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"pntd.0013053.ref030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1573403X15666190306111812","article-title":"Hyponatremia in Heart Failure: Pathogenesis and Management","volume":"15","author":"M Rodriguez","year":"2019","journal-title":"Curr Cardiol Rev"},{"issue":"7","key":"pntd.0013053.ref031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003123","article-title":"Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial","volume":"9","author":"VG Florea","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"23","key":"pntd.0013053.ref032","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1161\/CIRCULATIONAHA.113.006855","article-title":"Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes","volume":"129","author":"A Basuray","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"pntd.0013053.ref033","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cardfail.2011.03.005","article-title":"Heart failure with recovered ejection fraction: a distinct clinical entity","volume":"17","author":"LR Punnoose","year":"2011","journal-title":"J Card Fail"},{"issue":"5","key":"pntd.0013053.ref034","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardfail.2017.09.005","article-title":"Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial","volume":"24","author":"K-W Chang","year":"2018","journal-title":"J Card Fail"},{"issue":"9","key":"pntd.0013053.ref035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jchf.2015.04.011","article-title":"\u201cTargeting the Heart\u201d in Heart Failure: Myocardial Recovery in Heart Failure With Reduced Ejection Fraction","volume":"3","author":"JE Wilcox","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"4","key":"pntd.0013053.ref036","first-page":"1000","article-title":"Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction","volume":"13","author":"SA Leanc\u0103","year":"2023","journal-title":"Life (Basel)"},{"issue":"8","key":"pntd.0013053.ref037","article-title":"Reverse Cardiac Remodeling: Implication of the Etiology","volume":"16","author":"R Yau","year":"2010","journal-title":"Journal of Cardiac Failure"},{"issue":"3","key":"pntd.0013053.ref038","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/ehf2.13801","article-title":"Characterization of heart failure patients with reverse left ventricular remodelling post-angiotensin receptor blockers\/neprilysin inhibitors therapy","volume":"9","author":"L Maizels","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"10254","key":"pntd.0013053.ref039","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"F Zannad","year":"2020","journal-title":"Lancet"},{"issue":"10244","key":"pntd.0013053.ref040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"M Vaduganathan","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"pntd.0013053.ref041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2011.10.001","article-title":"Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF","volume":"163","author":"JE Wilcox","year":"2012","journal-title":"Am Heart J"},{"issue":"5","key":"pntd.0013053.ref042","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"DG Kramer","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"pntd.0013053.ref043","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","article-title":"Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study","volume":"59","author":"JC Hsu","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pntd.0013053.ref044","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/heartjnl-2023-322371","article-title":"Parameters associated with improvement of systolic function in patients with heart failure","volume":"110","author":"LB Sch\u00f6ps","year":"2023","journal-title":"Heart"},{"issue":"21","key":"pntd.0013053.ref045","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.jacc.2018.08.2195","article-title":"Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy","volume":"72","author":"T Senra","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pntd.0013053.ref046","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.carpath.2005.10.002","article-title":"QT interval dispersion in patients with chronic heart failure secondary to Chagas\u2019 cardiomyopathy: correlation with clinical variables of prognostic significance","volume":"15","author":"HAR Corbucci","year":"2006","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"pntd.0013053.ref047","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.CIR.0000079174.13444.9C","article-title":"Prognostic value of QT interval parameters for mortality risk stratification in Chagas\u2019 disease: results of a long-term follow-up study","volume":"108","author":"G Salles","year":"2003","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013053","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T18:13:57Z","timestamp":1746814437000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013053"}},"subtitle":[],"editor":[{"given":"Claudia Ida","family":"Brodskyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013053","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0013053","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}